BAQSIMI ® (BAK-see-mee) is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes ages 1 year and above. It is not known if BAQSIMI is safe …

May 14, 2025 · Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 year and older with diabetes. It is a nasal powder that is administered into the nose, …

Jan 16, 2025 · Baqsimi is commonly used to increase blood sugar (glucose) levels in people with dangerously low glucose levels (severe hypoglycemia). Baqsimi is used only during emergencies.

BAQSIMITM is indicated for the treatment of severe hypoglycemia in adults and pediatric patients aged 1 year and older with diabetes. BAQSIMI is for intranasal use only. Instruct patients and...

BAQSIMI is a preservative-free, white powder for intranasal administration in an intranasal device containing one dose of 3 mg glucagon. BAQSIMI contains glucagon as the active ingredient and …

On Monday, April 24, 2023, Eli Lilly announced that it would divest its glucagon product, Baqsimi, to Amphastar, in an effort to expand the availability of this first and only nasally administered glucagon …

Jul 26, 2024 · Learn about the cost, dosage, and more for Baqsimi (glucagon), a prescription powder that treats low blood sugar in adults and some children with diabetes.

May 13, 2020 · Baqsimi (glucagon) is a prescription drug used to treat severe hypoglycemia in adults and children. Learn about its shelf life, dosage, side effects, and more.

Apr 24, 2023 · Amphastar expects to provide dedicated commercial investment for BAQSIMI with the goal of enabling more people on insulin to be prepared with a glucagon rescue treatment for severe …

Aug 6, 2025 · BAQSIMI™ is indicated for the treatment of severe hypoglycemia in adults and pediatric patients aged 1 year and older with diabetes.